Deficiency of DDI2 suppresses liver cancer progression by worsening cell survival conditions

Related articles

1. Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities

   This article has 13 authors:

   1. Jianfeng Ge
   2. Shoko Hirosue
   3. Saroor A. Patel
   4. Ludovic Wesolowski
   5. Anna Dyas
   6. Cissy Yong
   7. Leticia Castillon
   8. Sanne de Haan
   9. Jarno Drost
   10. Grant D. Stewart
   11. Anna C. Obenauf
   12. Daniel Muñoz-Espín
   13. Sakari Vanharanta

2. p53 status determines the epigenetic response to demethylating agents Azacitidine and Decitabine

   This article has 6 authors:

   1. Emma Langdale Hands
   2. Arndt Wallmann
   3. Gabrielle Oxley
   4. Sophie Storrar
   5. Rochelle D’Souza
   6. Mathew Van de Pette

3. Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion Formation

   This article has 40 authors:

   1. Sivareddy Kotla
   2. Jonghae Lee
   3. Kyung Ae Ko
   4. Weiqing Chen
   5. Venkata Subrahmanya Kumar Samanthapudi
   6. Oanh Hoang
   7. Gilbert F. Mejia
   8. Shengyu Li
   9. Keri L. Schadler
   10. Luis Antonio Rivera
   11. Masaki Imanishi
   12. Kay Carlene Tavares Samperio
   13. Jung Hyun Kim
   14. Kelia C. Ostos-Mendoza
   15. Karla N. Mariscal-Reyes
   16. Anita Deswal
   17. John P. Cooke
   18. Keigi Fujiwara
   19. Nicolas L. Palaskas
   20. Efstratios Koutroumpakis
   21. Young Jin Gi
   22. Rajneesh Pathania
   23. Criag Morrell
   24. Philip L. Lorenzi
   25. Lin Tan
   26. Iqbal Madhmud
   27. Nordin M.J. Hanssen
   28. Laurent Yvan-Charvet
   29. Eduardo N. Chini
   30. Joerg Herrmann
   31. Hernan G. Vasquez
   32. Ying H. Shen
   33. James F. Martin
   34. Haodong Xu
   35. Erin H Seeley
   36. Jared K. Burks
   37. Paul S. Brookes
   38. Guangyu Wang
   39. Nhat-Tu Le
   40. Jun-ichi Abe